The WACC of Promore Pharma AB (PROMO.ST) is 5.9%.
| Range | Selected | |
| Cost of equity | 3.70% - 8.60% | 6.15% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 3.7% - 8.1% | 5.9% |
| Category | Low | High |
| Long-term bond rate | 2.8% | 3.3% |
| Equity market risk premium | 5.5% | 6.5% |
| Adjusted beta | 0.16 | 0.73 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 3.70% | 8.60% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 0.12 | 0.12 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 3.7% | 8.1% |
| Selected WACC | 5.9% | |